95 related articles for article (PubMed ID: 26237440)
1. IPF, comorbidities and management implications: Patient case 1.
Kreuter M
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():24-5. PubMed ID: 26237440
[TBL] [Abstract][Full Text] [Related]
2. Challenges in the classification of fibrotic ILD: Patient case 2.
Wijsenbeek M
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():13-6. PubMed ID: 26237438
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the classification of fibrotic ILD: Patient case 1.
Manali ED
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():10-2. PubMed ID: 26237437
[TBL] [Abstract][Full Text] [Related]
4. Challenges in IPF diagnosis, current management and future perspectives: Patient case 1.
Egan J
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():36-7. PubMed ID: 26237443
[TBL] [Abstract][Full Text] [Related]
5. IPF, comorbidities and management implications: Patient case 2.
Hilberg O
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():26-7. PubMed ID: 26237441
[TBL] [Abstract][Full Text] [Related]
6. [Idiopathic pulmonary fibrosis--a case report].
Munteanu O
Pneumologia; 2010; 59(3):158-63. PubMed ID: 21058469
[TBL] [Abstract][Full Text] [Related]
7. Challenges in IPF diagnosis, current management and future perspectives: Patient case 2.
Margaritopoulos G
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():38-9. PubMed ID: 26237444
[TBL] [Abstract][Full Text] [Related]
8. Practical management of Idiopathic Pulmonary Fibrosis.
Kishaba T
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):90-8. PubMed ID: 26278687
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic pulmonary fibrosis in a referral center in Iran: are patients developing the disease at a younger age?
Hashemi Sadraei N; Riahi T; Masjedi MR
Arch Iran Med; 2013 Mar; 16(3):177-81. PubMed ID: 23432171
[TBL] [Abstract][Full Text] [Related]
10. Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
Ryerson CJ; Cottin V; Brown KK; Collard HR
Eur Respir J; 2015 Aug; 46(2):512-20. PubMed ID: 26232481
[TBL] [Abstract][Full Text] [Related]
11. Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.
Alhamad EH; Masood M; Shaik SA; Arafah M
Clin Respir J; 2008 Oct; 2(4):220-6. PubMed ID: 20298338
[TBL] [Abstract][Full Text] [Related]
12. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis.
Cai M; Zhu M; Ban C; Su J; Ye Q; Liu Y; Zhao W; Wang C; Dai H
Chin Med J (Engl); 2014; 127(10):1868-73. PubMed ID: 24824247
[TBL] [Abstract][Full Text] [Related]
14. Update in idiopathic pulmonary fibrosis.
Frankel SK; Schwarz MI
Curr Opin Pulm Med; 2009 Sep; 15(5):463-9. PubMed ID: 19550329
[TBL] [Abstract][Full Text] [Related]
15. Challenges in IPF diagnosis, current management and future perspectives.
Wells AU; Costabel U; Poletti V; Crestani B; Egan J; Margaritopoulos G; Antoniou K
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():28-35. PubMed ID: 26237442
[TBL] [Abstract][Full Text] [Related]
16. A 65-year-old man with persistent cough and large nodular opacity.
Grimes BS; Albores J; Barjaktarevic I
Chest; 2015 Jan; 147(1):e13-e17. PubMed ID: 25560867
[TBL] [Abstract][Full Text] [Related]
17. A Nonsmoker Man in His 40s With a Diagnosis of Genetic-Related Idiopathic Pulmonary Fibrosis (Surfactant-Protein C Gene Mutation).
Fattori A; Ohana M; Hirschi S; Kessler R; Santelmo N; Nathan N; Chenard MP; Raymond S; Legendre M; Calabrese F
Chest; 2019 Apr; 155(4):e91-e96. PubMed ID: 30955586
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic pulmonary fibrosis: evolving concepts.
Ryu JH; Moua T; Daniels CE; Hartman TE; Yi ES; Utz JP; Limper AH
Mayo Clin Proc; 2014 Aug; 89(8):1130-42. PubMed ID: 24867394
[TBL] [Abstract][Full Text] [Related]
19. [Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis].
Bonella F; Wessendorf TE; Costabel U
Dtsch Med Wochenschr; 2013 Mar; 138(11):518-23. PubMed ID: 23423955
[TBL] [Abstract][Full Text] [Related]
20. Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation.
Richeldi L
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S181-5. PubMed ID: 26595737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
